<DOC>
	<DOCNO>NCT02704923</DOCNO>
	<brief_summary>A double-blind , placebo control trial atropine eye drop use sublingual way prevent Ventilator-Associated Pneumonia .</brief_summary>
	<brief_title>Atropine Preventing Ventilator-Associated Pneumonia</brief_title>
	<detailed_description>A double-blind , placebo control trial atropine eye drop use sublingual way prevent Ventilator-Associated Pneumonia conduct Passo Fundo - RS , south Brazil . 40 adult patient include ( exploratory stage 2 trial ) . Interventions initiate 48 hour patient submit orotracheal intubation : 2 drop atropine ( eye drop ) sublingual way , compare placebo regimen . Efficacy outcomes pneumonia death , safety also assess . No difference observe placebo atropine group term efficacy safety outcome . The small sample significance difference term initiate intervention ( median : 48h atropine ; 24h placebo ) may conservative bias . This exclude possible benefit atropine well evaluate stage 3 trial .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adult patient admit intensive care unit endotracheal intubation ventilator initiate 48 hour Pneumonia , radiotherapy , chemiotherapy , condition interfere saliva production change normal oral cavity shape</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Atropine</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Ventilator</keyword>
	<keyword>Adults</keyword>
	<keyword>Intensive care unit .</keyword>
</DOC>